Eisenhut, Katharina
Buchka, Stefan
Eichhorn, Peter
Meier, Harald
Albashiti, Fady
Mansmann, Ulrich
Schlüter, Miriam
Havla, Joachim
Kümpfel, Tania http://orcid.org/0000-0001-7509-5268
Funding for this research was provided by:
bundesministerium für bildung und forschung (01ZZ1603[A-D], 01ZZ1804[A-H] (DIFUTURE), 01ZZ1603[A-D], 01ZZ1804[A-H] (DIFUTURE), 01ZZ1603[A-D], 01ZZ1804[A-H] (DIFUTURE), 01ZZ1603[A-D], 01ZZ1804[A-H] (DIFUTURE))
Ludwig-Maximilians-Universität München
Article History
Received: 2 August 2021
Revised: 22 September 2021
Accepted: 22 September 2021
First Online: 5 October 2021
Declarations
:
: MS, KE, SB, HM, FA, UM, and PE report no disclosures relevant to the manuscript. JH reports grants for OCT research from the Friedrich-Baur-Stiftung and Merck, personal fees and non-financial support from Celgene, Merck, Alexion, Novartis, Roche, Santhera, Biogen, Heidelberg Engineering, Sanofi Genzyme and non-financial support of the Guthy-Jackson Charitable Foundation, all outside the submitted work. TK has received travel expenses and personal compensation from Bayer Healthcare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis/Genzyme, Roche, and Biogen, as well as grant support from Bayer Schering AG, Novartis, and Chugai Pharma, all outside the submitted work.
: The study was performed in accordance with the Helsinki II Declaration and approved by the ethics committee of the medical faculty of LMU Munich (project no 20-1081).
: All participants gave written informed consent prior to inclusion into the study.
: We thank all included participants for their consent to publish the study.